Dose requirements of hydralazine in patients with severe chronic congestive heart failure
- 31 March 1980
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 45 (3), 655-660
- https://doi.org/10.1016/s0002-9149(80)80019-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Hydralazine in the management of left ventricular failureThe American Journal of Cardiology, 1979
- Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure.Cell Metabolism, 1979
- Relationship between initial systemic vascular resistance and the response to vasodilators in severe congestive heart failureThe American Journal of Cardiology, 1979
- Beneficial effects of hydralazine in severe mitral regurgitation.Cell Metabolism, 1978
- Dose dependent reduction in right and left ventricular filling pressures with hydralazineThe American Journal of Cardiology, 1978
- Hemodynamic Improvement after Oral Hydralazine in Left Ventricular FailureAnnals of Internal Medicine, 1977
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- HydralazineNew England Journal of Medicine, 1976
- Treatment of Essential Hypertension with Combined Vasodilation and Beta-Adrenergic BlockadeNew England Journal of Medicine, 1972
- Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failureAmerican Journal Of Medicine, 1965